e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Progresses in granolomatous lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chitotriosidase as a possible marker of sarcoidosis activity
E. Bargagli, P. Anna, M. M. Antonietta, S. Grosso, P. Rottoli (Siena, Italy)
Source:
Annual Congress 2005 - Progresses in granolomatous lung disease
Session:
Progresses in granolomatous lung disease
Session type:
Oral Presentation
Number:
3067
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bargagli, P. Anna, M. M. Antonietta, S. Grosso, P. Rottoli (Siena, Italy). Chitotriosidase as a possible marker of sarcoidosis activity. Eur Respir J 2005; 26: Suppl. 49, 3067
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
The role of isoenzymes levels of ‘adenosine deaminase‘ in bronchoalveolar lavage fluid to determining activitiy of pulmonary tuberculosis
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Involvement of lymphocytes in
mycoplasma pneumoniae
pneumonia is associated with elevation in KC, IL-6 and TNF-α levels in bronchoalveolar lavage fluid
Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens
Year: 2007
Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF)
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Detection of extracellular proteasome in the human alveolar space
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
Source: Eur Respir J 2003; 21: 407-413
Year: 2003
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients
Source: Eur Respir J 2003; 21: 52-57
Year: 2003
CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL
Source: Eur Respir J 2003; 22: 497-502
Year: 2003
Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Source: Eur Respir J 2004; 24: 1000-1006
Year: 2004
Sputum rather than bronchoalveolar lavage (BAL) cells are associated with small airways function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 198s
Year: 2002
Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003
Biochemical markers in bronchoalveolar lavage (BAL)
Source: Eur Respir J 2001; 18: Suppl. 33, 385s
Year: 2001
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept